Mark Grinstaff
William Fairfield Warren Distinguished Professor (BME, Chemistry, MSE, MED)
2026 REU Project: Coming Soon
Dr. Mark Grinstaff is a professor of Biomedical Engineering (BME), Chemistry (CHEM), Materials Science and Engineering (MSE), and Medicine (MED) at Boston University. He is also the Director of the NIH T32 Program in Translational Research in Biomaterials (TRB) and the Nanotechnology Innovation Center (BUnano) at Boston University.
The Grinstaff Group studies polymers, biomaterials, nanomaterials, wound repair, and tissue engineering. The lab pursues highly interdisciplinary research in the areas of biological and macromolecular chemistry to elucidate fundamental chemistry and engineering principles and use that insight to direct the lab’s creative and scientific efforts. The Grinstaff Group
designs, synthesizes, and characterizes novel dendrimers, termed “biodendrimers,” for tissue engineering and biotechnological applications. They evaluate these novel biomaterials for the repair of corneal lacerations, for the delivery of anti-cancer drugs, for the delivery of DNA, and as temporary biodegradable scaffolds for cartilage repair. The group creates novel polymeric coatings termed “interfacial biomaterials” that control biology on plastic, metal, and ceramic surfaces. And they design electrochemical-based sensors/devices using conductive polymer nanostructures and specific DNA structural motifs.
Previous REU/RET Projects Include:
- Characterizing Relaxin-2 as a Therapeutic Candidate for Fibrosis (REU, 2025)
- RNA Delivery for Therapeutic Applications (REU, 2023)
- Departments
- Biomedical Engineering, Chemistry, Materials Science Engineering, and Medicine
- Affiliation
- Faculty
- Program Year
- 2023 and 2025
- Fields
- REU